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Background: Phosphorylation and TPX2 act together to stabilize the active conformation of Aurora-A.
Results: TPX2 activates unphosphorylated Aurora-A, although phosphorylation makes a 2-fold greater energetic contribution
to catalysis than TPX2.
Conclusion: Either activator partially stabilizes the active conformation and stimulates kinase activity.
Significance:Our revised model of kinase activation and mechanistic analysis might be applicable to other kinases.
Protein kinases are activated by phosphorylation and by the
binding of activator proteins. The interplay of these two factors
is incompletely understood. We applied energetic analysis to
this question and characterized the activation process of the ser-
ine/threonine kinase Aurora-A by phosphorylation and by its
protein partner, targeting protein for Xenopus kinesin-like pro-
tein 2 (TPX2). We discovered that these two activators act syn-
ergistically and without a predefined order: each can individu-
ally increase the activity of Aurora-A, and the effect of both
bound together is the exact sum of their individual contribu-
tions to catalysis. Unexpectedly, the unphosphorylated enzyme
has catalytic activity that is increased 15-fold by the binding of
TPX2 alone. The energetic contribution of phosphorylation to
catalysis is 2-fold greater than that of TPX2 binding, which is
independent of the phosphorylation state of the enzyme. Based
on this analysis, we propose a revised, fluid model of Aurora-A
activation in which the first step is a reduction in themobility of
the activation loop by either TPX2 binding or phosphorylation.
Furthermore,ourresultssuggestthatunphosphorylatedAurora-
A bound to the mitotic spindle by TPX2 is catalytically active
and that the phosphorylation state of Aurora-A is an inaccurate
surrogate for its activity. Extending this form of analysis will
allow us to compare quantitatively the effects of the whole net-
work of kinase-activating partners. Comparison with other
kinases showed that kinetic characterization detects those
kinases whose activation loops undergo a rearrangement upon
phosphorylation and thus whose unphosphorylated state offers
a distinct target for the development of Type II inhibitors.
Protein kinases catalyze many of the reactions crucial to cel-
lular control. They often act in complexes with different bind-
ing partners, and these protein partners can act as regulatory
units or confer substrate specificity (1). Themajority of protein
kinases are also regulated by phosphorylation on a region of
their sequence known as the activation loop. Phosphorylation
may be carried out autocatalytically or by the action of a regu-
latory kinase as part of a signaling cascade or network of
interactions.
Given the ubiquitous nature of these control mechanisms, it
is surprising how few quantitative studies there are of kinase
activation. Instead, molecular biology, systems biology, and
drug discovery programs have all made the approximation of a
two-state system: either on or off, active or inactive (1–3). The
first detailed characterization of activation kinetics was of pro-
tein kinase A (PKA), which is activated by a single phospho-
threonine (Thr(P)) residue. Phosphorylation of this residue
increases the rate of catalysis and also prevents rebinding of the
inhibitory PKA regulatory subunit (4). This was followed by
work on CDK2,3 but the limitations of detection of the assay
system used meant that characterization was only possible for
the binding of cyclin A to the phosphorylated kinase and the
phosphorylation of cyclin-bound CDK2 (5). Although many
conformations of CDK2 have been characterized structurally,
this meant that a full study of the interactions of phosphoryla-
tion and cyclin binding could not be carried out. The only
kinase we have found for which the interaction of multiple fac-
tors has beenmeasured is themitogen-activated protein kinase
ERK2, which requires a double phosphorylation on the activa-
tion loop for full activity (6). Structures are available of un- and
doubly phosphorylated ERK2, but the absence of monophos-
phorylated structures hampers the analysis of the relationship
between structure and energetics. Remarkably, we have not
been able to find a published characterization of the interaction
of phosphorylation and a protein activator for any kinase.
Aurora-A is an oncogene-associated serine/threonine kinase
active at the G2/M transition of mitosis and is currently the
target of a number of drug discovery programs (7, 8). It localizes
to the centrosome and to the mitotic spindle and binds to a
number of different protein partners in vivo, the best charac-
terized ofwhich isTPX2. Binding of theN-terminal fragment of
TPX2 to Aurora-A activates the kinase by a factor of 2–7
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depending on the assay used (9–11). The x-ray crystal structure
of the complex of TPX2 bound to phosphorylated Aurora-A
showed that TPX2 interacts with both the N-terminal lobe and
the activation loop, holding the kinase in an active conforma-
tion (10).
In this study, we characterized the four possible stages of
activation of Aurora-A by two activators: phosphorylation and
TPX2 binding.We addressed several outstanding issues such as
the contribution of each activator to Aurora-A catalysis and
whether TPX2 can stimulate the activity of unphosphorylated
Aurora-A through an allostericmechanism.Our findings led us
to a fluid model of Aurora-A activation in which the first acti-
vator induces order in the activation loop in addition to having
an activator-specific effect. Our data support a revisedmodel of
the activity of Aurora-A across the mitotic spindle in which
unphosphorylated Aurora-A has a kinase-dependent role.
Finally, analysis of the literature in the light of our new data
shows that rearrangement of the activation loop upon phos-
phorylation can be detected using kinetic characterization.
This provides an alternativemethod to x-ray crystallography to
select kinases with a distinct inactive conformation that can
then be targeted with an inhibitor discovery program (12).
EXPERIMENTAL PROCEDURES
Protein Expression—Point mutants of human Aurora-A
kinase domain (residues 122–403) were generated using a
QuikChange protocol, and all proteins were expressed with an
N-terminal His6 tag and linker region in Escherichia coli using a
pET30-based vector in LB medium (initial growth at 37 °C fol-
lowed by 21 °C overnight after induction with isopropyl -D-1-
thiogalactopyranoside). Bacterial pellets were resuspended in
50 mM Tris, pH 7.5, 300 mM NaCl, 5 mM MgCl2, 40 mM imid-
azole, 10% (v/v) glycerol; lysed; and filtered, and tagged protein
was separated from crude lysate using nickel affinity chroma-
tography. The bound fraction was eluted using a step gradient
of the same buffer (except with 250 mM imidazole), concen-
trated, and purified to homogeneity using a buffer of 50 mM
Tris, pH 7.5, 200 mM NaCl, 5 mMMgCl2, 10% (v/v) glycerol, 10
mM -mercaptoethanol on either an S75 or S200 column.
Resulting fractions were concentrated to around 10mg/ml and
flash frozen for future use.
TPX2 (residues 1–43) was expressed as for Aurora-A. Bac-
terial pellets were resuspended in 50 mM Tris, pH 7.5, 150 mM
NaCl, 20mM imidazole for nickel affinity chromatography, and
bound protein was eluted with 250 mM imidazole (other buffer
constituents were as before). Eluted fractions were concen-
trated and then gel-filtered on an S75 column in the samebuffer
as for Aurora-A.
Kinetic Measurements—Kinetic assays were carried out in
duplicate in gel filtration buffer using 1.5 M fluorescein-la-
beled substrate (Flu-LRRASGL, Caliper peptide 21) in a Caliper
EZ Reader II system at room temperature (assumed to be 298
K). Enzyme concentrations were as follows: Km measurements
in the absence of TPX2 and TPX2 titration, 3 nM (WT and
T287A), 800 nM (T288A), and 3 M (T287A/T288A); Km mea-
surements in the presence of TPX2, 3 nM (WT andT287A), 222
nM (T288A), and 1 M (T287A/T288A). Km measurements
were made using a 2-fold serial dilution from the highest con-
centration. The final reaction volume was 25 l.
Kinetic Analysis—The contribution of a functional group to
the energetics of catalysis can be determined by the ratio of
kcat/Km in the presence and absence of the group (13, 14) as
follows in Equation 1,
FIGURE 1. Reaction scheme and free energy diagrams for Aurora-A catal-
ysis. a, reaction scheme for a kinase following a random sequential mecha-
nism: first one substrate binds (either A or B), then the other binds to form a
triple complex, which reacts to formproducts P andQ. b, free energy diagram
for the reaction scheme in a. GiA RT ln Kia, GmA RT ln KmA, and Gcat 
RT ln kcat. EAB
‡ denotes the high energy transition state of the phospho-
transfer reaction. The relative positions of EA and EB on the reaction coordi-
nate are arbitrary. Relative positions on the y axis have been drawn assuming
saturating quantities of A and limiting quantities of B. These positions are
arbitrary, and changing the concentration of reactants will only affect the
position on the y axis and not the nomenclature or conclusions of this figure.
c, simplified free energy diagram for the case where [B] KmB. In this case,
Gcat encompasses the energetics of forming the triple complex and forming
the high energy transition state and is proportional to a pseudo-kcat as shown
in the main text. Our assay conditions for Aurora-A are an example of this
special case, and Km and kcat measurements presented in this study refer to
the quantities shown in this figure.
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FIGURE 2.Normalized activity of Aurora-A andmutants. a, Km for ATP determined for enzyme alone. b, TPX2 titration in 2mM ATP (1mM ATP for wild type).
c, Km for ATP determined in the presence of 20 M TPX2 (5 M TPX2 for wild type). Red solid line, wild type; red dashed line, T287A; blue solid line, T288A; blue
dashed line, T287A/T288A. Red graphs are plotted on the left y axis, and blue graphs are plotted on the right y axis. All graphs are normalized for enzyme
concentration. Error bars show S.E. of reaction rates (i.e. S.E. of the slope determined by linear regression of reaction time courseswith each time course carried
out in duplicate and replicate data fitted together).
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GX  Y
‡  RT lnkcatX /KmXkcatY /KmY  (Eq. 1)
where X is the enzyme in the presence of the functional group,
Y is the enzyme in its absence, andG‡ is the free energy change
between the activated transition state for the reaction and the
enzyme  substrate ground state (equal to Gcat  GmA in
Fig. 1).
Unlike many textbook examples, a kinase is a two-substrate
enzyme, and bothATP and peptide need to bind before transfer
of the -phosphate group and release of ADP (Fig. 1). The rate
of the reaction shown in Fig. 1b is given in Equation 2.
v 
kcat[E]AB
KiAKmB KmBA KmAB AB
(Eq. 2)
This can be rewritten as
v 
kcat
pseudo[E]A
KmA
app A
(Eq. 3)
using Equations 4 and 5.
kcat
pseudo
kcatB
KmB B
(Eq. 4)
KmA
app
KmAB KiAKmB
KmB B
(Eq. 5)
In the case where [B] KmB, Equations 6 and 7 are used, thus
yielding Equation 8.
kcat
pseudo
kcat[B]
KmB
(Eq. 6)
KmA
app
KiA	1 KmAB/KiAKmB

1 B/KmB
 Kia (Eq. 7)
kcat
pseudo
KmA
app 
kcatB
KmBKiA
(Eq. 8)
Mechanistic analysis of Aurora-A has shown that catalysis pro-
ceeds according to a random sequential mechanism (9), and
under our assay conditions ([substrate peptide] Km for sub-
strate) Fig. 1b simplifies to Fig. 1c.
RESULTS
Kinetic Characterization of Aurora-A Kinase and Phospho-
site Mutants in Presence and Absence of TPX2—We have pre-
viously used an automated kinase assay system based on the
phosphorylation of a fluorescein-labeled peptide substrate to
investigate the chemical inhibition of Aurora-A (15). The high
quality and reproducibility of the data suggested to us that this
assay would enable a detailedmechanistic analysis of the kinase
including states thatmight exhibit a very low substrate turnover
such as the unphosphorylated kinase.
The activation loop of Aurora-A contains two adjacent thre-
onine residues, Thr-287 and Thr-288, and the phosphorylation
of Thr-288 has been shown to increase the activity of the
enzyme in cell extracts (16). To distinguish their effects, we
mutated each residue to alanine (T287A, T288A, and the dou-
ble mutant T287A/T288A) and characterized the activities of
the resulting enzymes (Fig. 2a and Table 1). Mass spectrometry
was unable to distinguish between phosphorylation at positions
287 and 288 of the tryptic digest peptide encompassing these
residues but verified that wild-type and T287A mutants were
phosphorylated. No phosphorylation was detected for the
T287A/T288Adoublemutant (as expected) or, surprisingly, for
Thr-287 in the T288A mutant. All four enzymes were catalyti-
cally active, although phosphorylation at position 288 undoubt-
edly increased the kcat and decreased the Km for ATP.
Aurora-A is activated at themitotic spindle by the binding of
TPX2 (10, 11). We determined the concentration of TPX2
required to saturate the activation of wild-type and mutant
Aurora-A proteins (Fig. 2b) and then characterized the kinetic
parameters of Aurora-A under these conditions. Unexpectedly,
TPX2 was able to increase the activity of unphosphorylated
Aurora-A (Fig. 2, b and c, andTable 1), although this was appar-
ent at a higher concentration of TPX2 than that required for
activation of the phosphorylated enzyme. Binding of TPX2 to
Aurora-Adecreased theKm forATP and increased the kcat in all
contexts, although the factor change was dependent on the
presence or absence of Thr(P)-288.
Phosphorylated, unphosphorylated, TPX2-bound, and
TPX2-free constitute four possible states of Aurora-A. The rel-
ative catalytic activity of these states (i–iv) are summarized on a
relative scale in Fig. 3a, which shows that the most active form
of the kinase is roughly 500-fold more active than the least
active.
Phosphorylation andTPX2BindingAct Independently—Two
activators of catalysis may be independent of one another (the
effect of both is the simple sum of the effects of each alone) or
may exhibit cooperativity (the effect of both is greater than the
sumof the effects of each individually). These two scenarios can
be distinguished from one another by quantifying the energetic
TABLE 1
Activity of Aurora-A constructsa
Values are for the fitting average of duplicate measurements. Errors are fitting
errors.
aWe were not able to measure a Km for peptide of Aurora-A using our assay sys-
tem (Km 500 M for a selection of peptides including a physiological substrate
sequence), and so this value is a pseudo-kcat incorporating the effects of sub-
strate binding (full details are under “Kinetic Analysis” under “Experimental
Procedures”).
b Values determined in presence of 5 M TPX2 (wild type) or 20 M TPX2 (other
constructs).
cMeasured in excess ATP: 1 mM ATP (wild type) and 2 mM ATP (other con-
structs).
d Larger error due to curve barely reaching saturation at highest concentration of
TPX2.
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contribution of an activator to catalysis (see “Experimental Pro-
cedures” for details).
We calculated the effect of phosphorylation and TPX2 bind-
ing on catalysis by Aurora-A both individually and together
(Table 2). TPX2 contributes 2.1  0.2 kcal mol1 to catalysis
irrespective of the phosphorylation state of Aurora-A, thus
showing that TPX2 and phosphorylation act independently of
one another. This compares excellently with a value of 2.3 0.4
kcal mol1 for TPX2 in the context of the phosphorylated
kinase calculated from independent data in Ref. 9. The compa-
rable value for the contribution of cyclin A to phosphorylated
CDK2 is 7 kcal mol1, and the value for unphosphorylated
CDK2 is unknown (17).
We calculated the contribution of a single Thr(P) at position
288 to catalysis by comparing T287A and T287A/T288A (these
differ by exactly one Thr(P): Thr(P)-288). This is different from
comparing wild type and T288A, which differ by both Thr(P)-
288 and Thr(P)-287 (Thr-287 is not phosphorylated in T288A
mutant). The contribution of phospho-Thr-288 to the catalysis
of phosphate transfer is 4.3 0.2 kcal mol1 (average of line 1
subtracted from line 3 inTable 2). Calculating a similar quantity
from values provided in the literature for other kinases gives
values ranging from 1.1 to 6.5 kcal mol1 (Table 3). The contri-
bution is greatest for CDK2 (6.5 kcal mol1) and lowest for the
phosphorylation of Thr(P)-183ERK2 on the previously Tyr-
phosphorylated background (1.1 kcal mol1). The value for
Thr(P)-288 in Aurora-A (4.4  0.3 kcal mol1) lies between
these two extremes. This compares with the energies contrib-
uted to catalysis of up to around 7 kcal mol1 for a hydrogen
bond, 4 kcal mol1 for a salt bridge, and 3 kcal mol1 for the
contribution of a single methyl group (13).
DISCUSSION
Fluid Model of Aurora-A Activation—To better understand
Aurora-A activation, we calculated the way in which the ener-
FIGURE 3. Two parallel paths of Aurora-A activation give rise to four different states of activity. a, the four different states of Aurora-A are shown
schematically, each labeledwitha romannumeral (i–iv), andaredistributedona vertical scale to indicate thecatalytic activity relative to the lowest activity state.
Numbers in bold (1–4) label each step for reference but have no numerical order or meaning. Kinetic constants indicate the approximate -fold change in the
constant uponcompletionof the step. Each step is labeledwith the associated -fold change in kinetic parameters. Thiswas calculated in twodifferentways: the
effect of phosphorylation in as close to physiological circumstances as possible (WT compared with T288A) and in brackets the effect of phosphorylation on
Thr-288 alone (T287A compared with T287A/T288A). A fifth, dashed arrow connects the two states of intermediate activity. b, model of Aurora-A activation
through stabilization of the activation loop (shown as a dashed line progressing to a solid line) and electrostatic communication between the phosphorylated
activation loop and the catalytic center (shown as a double headed arrow).
TABLE 2
Energetic contributions to catalysis
All values are in kcal mol1. Errors were propagated from the fitting errors in Table 1.
TPX2 TPX2
G‡WT-T287A 0.2 0.2 0.7 0.1
G‡WT-T288A 3.7 0.2 3.8 0.2
G‡WT-T287A/T288A 4.7 0.2 4.8 0.1
G‡WT(TPX2-noTPX2) 2.3 0.1
G‡T287A(TPX2-noTPX2) 1.8 0.2
G‡T288A(TPX2-noTPX2) 2.1 0.2
G‡T287A/T288A(TPX2-noTPX2) 2.2 0.1
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getic contribution of Aurora-A phosphorylation and TPX2
binding is divided between the Km for ATP and the kcat (Fig. 3).
The order of TPX2 binding and Aurora-A phosphorylation in
vivo is not known, and either pathway (1–2 or 3–4) may repre-
sent the situation at the mitotic spindle in cells. We discovered
that although the total energetic contributions of phosphory-
lation or TPX2 binding are independent of one another (Table
2), the physical implementations of this are not. For example,
phosphorylation of the free kinase (step 3) has a very small
effect on the Km for ATP and a large (160) increase in kcat,
whereas phosphorylation in the presence of TPX2 (step 2)
affects both parameters equally. Activation of the unphos-
phorylated kinase (step 1 or 3) is consistently associatedwith an
increase in kcat. Further activation is mostly in Km (step 4) or
equally distributed between the two parameters (step 2). The
significance of this will be discussed below.
Ourmeasurements onAurora-A cannot distinguish between
effects on peptide binding and effects on the rate of phosphoryl
transfer as our reported kcat is a pseudo-kcat including a contri-
bution from substrateKm. Either an increase in peptide binding
or an increase in stabilization of the transition state would
increase our measured value of kcat. However, we used the data
in Ref. 9 to subdivide the value shown in step 4 into a 3-fold
change inKm for peptide and a 1.2-fold change in true kcat. This
shows that, in this context, the effect of TPX2 is solely through
ATP binding and peptide Km.
How might this be interpreted with respect to the structural
and physical states of the kinase? The current model of the
interaction of multiple factors in kinase activation was pro-
posed for CDK2. This assigns each activator a well defined
physical effect that sum together to give the fully active complex
(5, 17). Cyclin A increases ATP binding and alignment and also
increases substrate binding by stabilizing the activation loop
conformation. The main effect of phosphorylation on Thr-
160CDK2 is stabilization of the transition state, but a small part
of its role is to increase substrate binding.
In contrast to this, we propose a fluid model of Aurora-A
activation based on our kinetic data and the observation from
crystal structures that increased levels of Aurora-A activity are
associated with increased order in the activation loop of the
kinase (Figs. 3b and 4a). The first activation step of free,
unphosphorylated Aurora is associated most strongly with
an increase in kcat (Fig. 3a, steps 1 and 3), and we propose
that part of this energy is used in ordering the activation loop
and increasing substrate binding irrespective of whether
TPX2 binding or phosphorylation occurs first (Fig. 3b). In
the second step of activation, the joint actions of phosphor-
ylation and TPX2 binding result in a decrease in the Km for
ATP that neither can bring about on its own (steps 2 and 4
compared with steps 1 and 3), whereas the majority of the
increase of kcat in step 2 is due to stabilization of charge in the
transition state by pThr-288 (which we would not expect
TABLE 3
Contribution of phosphorylated residues to catalysis
Kinase
and context Residue Context
Overall
contribution to
catalysisa
-Fold decrease
in Km for ATP
-Fold decrease
in Km for substrate
-Fold increase
in kcat
-Fold decrease
in Kd for substrate Ref.
kcal mol1
Aurora-A
WT Thr(P)-288b Activation loop 4.5 0.1c 3.0 0.2 700 100d —e This study
Bound to TPX2 Thr(P)-288b Activation loop 4.2 0.1c 18 2 70 10d — This study
CDK2
Bound to cyclin A Thr(P)-160f Activation loop 6.5 0.4g 1.4 0.7 140 40g 270 130 35 11g 17
Thr(P)-160/bound to
cyclin A
Tyr(P)-15f Glycine-rich loop
(inhibitory)
3.1 0.1 1.0 0.5 0.4 0.1 0.015 0.002
(decrease of 65 10)
— 23
PKA
WT Thr(P)-197b Activation loop 3.8 0.3h 90 25h,i 30 8h,i 6 1h,i 1.8 0.5h 4
v-Fps
WT Tyr(P)-1073j Activation loop 2.1 0.5k 1.1 0.5 2.6 0.8 42 9 0.7 0.4 24
p38
WT Thr(P)-180f Activation loopl 3.9 0.3m — — — — 25
WT Tyr(P)-182f Activation loopl 1.2 0.1m — — — — 25
Tyr(P)-182 Thr(P)-180f Activation loopl 4.5 0.1m — — — — 25
Thr(P)-180 Tyr(P)-182f Activation loopl 1.8 0.3m 7.9 0.5 4 1m 4 1m — 25
ERK2
WT Thr(P)-183b Activation loopl 1.9 1.2 2.5 80 2.5 6
WT Tyr(P)-185j Activation loopl 2.3 16 0.8 1000 0.8 6
Tyr(P)-185 Thr(P)-183f Activation loopl 1.1 0.9 14 50 120g 6
Thr(P)-183 Tyr(P)-185f Activation loopl 1.5 13 4.8 625 40g 6
a Calculated from kcat/(Km Kd).
b Compared with alanine.
c Calculated from Table 2.
d Increase in pseudo-kcat, which combines effect of true Km and kcat. These values are thus centered across two columns.
e—, cannot be determined from data provided.
f Compared with unphosphorylated residue.
gMinimum value.
h Assuming 10% error on wild type and making the same assumptions for Kd of substrate and equivalence of T197D and T197D-GST as in Ref. 4.
i Full analysis of the rate constants for PKA (26) have shown that Km(peptide) does not represent the dissociation constant of peptide and that kcat reflects the dissociation of
ADP. Therefore, discussion in the text uses the detailed analysis in Ref. 4, not the numbers shown here.
j Compared with phenylalanine.
kMaking the same assumptions for Kd of substrate for Y1073F as in Ref. 24.
l The activation loop of mitogen-activated protein kinases such as p38 and ERK2 contains a TXY motif, and phosphorylation on both the Thr and Tyr in this motif is re-
quired for complete activation.
m Calculated using EGF receptor as a substrate. Similar values were obtained using ATF2109.
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TPX2 to be able to do). The fluid model thus extends previ-
ous models of Aurora-A activation by TPX2 to include all
four relevant states of the kinase.
Structural Rearrangements Can Be Inferred from Kinetic
Measurements—The residues of the activation loop form part
of the substrate binding pocket, and we thus predict that order-
ing of the activation loop will increase substrate binding. This
prediction is supported by the data in Table 3 and associated
references: in those kinases (CDK2 and ERK2) in which there is
significant rearrangement of the activation loop upon phos-
phorylation, there is also an associated change in Kd for sub-
strate. This is not seen for those kinases (PKA and v-Fps) in
which there is little or no activation rearrangement (Fig. 4).
Kinetic characterization thus provides a promising tool to
detect those kinases in which phosphorylation leads to activa-
tion loop rearrangement. We expect such kinases to display a
signature of decreasing Kd for peptide and increasing kcat upon
phosphorylation. This test can be performed at low enzyme
concentrations in solution and provides conformational infor-
mation in the absence of a crystal structure. This information
could help inform decision-making in the drug discovery proc-
ess as kinases that undergo activation loop rearrangements are
likely to be more promising targets for the generation of inhib-
itors that bind the inactive conformation (e.g. Type II inhibi-
tors).
Is Spindle-associated Aurora-A Catalytically Active?—In
mitotic cells, Aurora-A is found at the centrosome (TPX2-in-
dependent) and on spindle microtubules (TPX2-dependent),
and it has previously been assumed that the kinase is both cat-
alytically active and phosphorylated at these locations. How-
ever, it has recently been shown that the role of Aurora-A
(AIR-1 in Caenorhabditis elegans) in chromatin-stimulated
microtubule assembly in C. elegans embryos does not require
phosphorylation on Thr-288 (Thr-201 in C. elegans) and that
unphosphorylatedAurora-A is localized to themicrotubules by
TPX2 (TPXL-1) (18). The authors concluded that the mecha-
nism of Aurora-A action was independent of kinase activity,
although they did not assess the catalytic activity of the unphos-
phorylated AIR-1 bound to TPXL-1. We have measured a con-
siderable increase in the kinase activity of unphosphorylated
Aurora-A upon binding to TPX2. Although the cellular con-
centration of TPX2 is not known, its localization in two dimen-
sions along the microtubules means that local concentrations
experienced by Aurora-A are expected to be high. This pro-
vides an alternative, kinase-dependent mechanism by which
TPX2Aurora-A complexes function to promote chromatin-
stimulated microtubule assembly.
DoesAurora-ALocalization and Function along SpindleMicro-
tubules Require Phosphorylation?—Closer inspection of immu-
nofluorescence studies in human cells discriminating between
whole Aurora-A and that phosphorylated on Thr-288 suggests
that only the pool of Aurora-A at the poles is phosphorylated
(19–21). There could be a technical explanation for these
observations, for example if the phosphorylated epitope is
masked along spindle microtubules. Arguing against this is the
fact that, in HeLa cells, phosphorylation of Aurora-A at the
spindle becomes apparent in the absence of protein phospha-
tase 6 (the physiological phosphatase acting against Aurora-A)
(22). It therefore seems likely that Aurora-A at spindle micro-
tubules is not stably phosphorylated on Thr-288, but it remains
to be confirmed whether the unphosphorylated Aurora-A is
functional in human cells. These recent studies, together with
our data, show that the regulation ofAurora-AbyTPX2 ismore
complex than previously thought.
Aurora-A catalyzes the phosphorylation of its own activation
loop, and consequently the phosphorylation state of Thr-288
on the activation loop of Aurora-A is frequently used as a cel-
lular readout of Aurora-A activity and of the extent of enzyme
FIGURE4.Activation loopsofkinases forwhichactivationprocesshasbeencharacterizedbykinetic studies.The crystal structures of activation loops are
shown fromDFG to APE sequencemotifs, whichmark the beginning and end, respectively, of the kinase activation loop. a, Aurora-A; b, PKA; c, p38; d, CDK2;
e, v-Fes, the human viral homologue to avian v-Fps; f, ERK2. Residues whose phosphorylation affects kinase activity are shown in stick representation. The
phosphate groups of the Thr(P) residues (Tyr(P) for v-Fes) superpose in the fully active kinases when the different molecules are aligned across the kinase
domain. Red, phosphorylated kinase; dark blue, unphosphorylated kinase; orange, phosphorylated Aurora-A bound to TPX2 (a only)/phosphorylated CDK2
bound to cyclin A (d only); cyan, unphosphorylated CDK2 bound to cyclin A (d only). Protein Data Bank codes selected are 1OL5, 1OL6, and 1OL7 (Aurora-A);
1BKX and 2UZW (PKA); 3PY3 and 1OUK (p38); 1B38, 1B39, 1JST, and 1FIN (CDK2); 3CBL and 3CD3 (v-Fes); and 1ERK and 2ERK (ERK2). The activation loop is not
visible in the unphosphorylated Aurora-A structure and is assumed to be disordered.
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inhibitionbysmallmolecules.Wehaveshownthatunphosphor-
ylated Aurora-A has catalytic activity and that this activity is
greatly increased in the presence of TPX2. Because TPX2 does
not protect Aurora-A from protein phosphatase 6 activity, a
pool of TPX2-bound, active, unphosphorylated Aurora-A will
be present in the cell. This pool is distinct from that of the
phosphorylated enzyme (18), and studies relying on Thr-288
phosphorylation alone as a biomarker of Aurora-A activity
may, unwittingly, limit their scope.
Conclusion—In conclusion, we have dissected the contribu-
tions of activation loop phosphorylation and protein partner
binding to the activation of the kinaseAurora-A.Unexpectedly,
the overall contribution of either activator is independent of the
presence or absence of the other. The way in which the energy
of activation is distributed between kcat and Km can be used to
predict whether the activation step involves structural rear-
rangement in the activation loop and thus can be used to test
whether pursuit of a Type II inhibitor program would be suita-
ble. Our data show that the kinase activity of unphosphorylated
Aurora-A can be increased by the binding of TPX2. This sup-
ports a newmodel of howAurora-A activity is spread across the
mitotic spindle in cells.
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